GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » DNA Chip Research Inc (TSE:2397) » Definitions » Cyclically Adjusted Revenue per Share

DNA Chip Research (TSE:2397) Cyclically Adjusted Revenue per Share : 円80.46 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is DNA Chip Research Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

DNA Chip Research's adjusted revenue per share for the three months ended in Dec. 2023 was 円16.791. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円80.46 for the trailing ten years ended in Dec. 2023.

During the past 12 months, DNA Chip Research's average Cyclically Adjusted Revenue Growth Rate was -3.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -7.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of DNA Chip Research was -7.60% per year. The lowest was -13.40% per year. And the median was -10.30% per year.

As of today (2024-06-10), DNA Chip Research's current stock price is 円896.00. DNA Chip Research's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円80.46. DNA Chip Research's Cyclically Adjusted PS Ratio of today is 11.14.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DNA Chip Research was 20.43. The lowest was 3.55. And the median was 6.87.


DNA Chip Research Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for DNA Chip Research's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DNA Chip Research Cyclically Adjusted Revenue per Share Chart

DNA Chip Research Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 115.52 100.74 87.50 83.37 79.37

DNA Chip Research Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.63 79.37 79.91 79.96 80.46

Competitive Comparison of DNA Chip Research's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, DNA Chip Research's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DNA Chip Research's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, DNA Chip Research's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DNA Chip Research's Cyclically Adjusted PS Ratio falls into.



DNA Chip Research Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DNA Chip Research's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=16.791/106.8000*106.8000
=16.791

Current CPI (Dec. 2023) = 106.8000.

DNA Chip Research Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 58.104 95.700 64.843
201406 8.057 98.000 8.780
201409 20.205 98.500 21.908
201412 11.238 97.900 12.260
201503 50.469 97.900 55.057
201506 7.959 98.400 8.638
201509 7.247 98.500 7.858
201512 8.103 98.100 8.822
201603 43.741 97.900 47.717
201606 4.331 98.100 4.715
201609 7.040 98.000 7.672
201612 12.609 98.400 13.685
201703 52.623 98.100 57.290
201706 8.534 98.500 9.253
201709 14.051 98.800 15.189
201712 19.219 99.400 20.650
201803 43.812 99.200 47.169
201806 10.169 99.200 10.948
201809 12.089 99.900 12.924
201812 15.453 99.700 16.553
201903 36.900 99.700 39.528
201906 9.712 99.800 10.393
201909 16.157 100.100 17.238
201912 11.076 100.500 11.770
202003 34.118 100.300 36.329
202006 5.127 99.900 5.481
202009 9.645 99.900 10.311
202012 13.675 99.300 14.708
202103 27.997 99.900 29.931
202106 6.741 99.500 7.236
202109 12.977 100.100 13.846
202112 18.243 100.100 19.464
202203 35.949 101.100 37.976
202206 5.118 101.800 5.369
202209 10.173 103.100 10.538
202212 13.440 104.100 13.789
202303 25.223 104.400 25.803
202306 10.614 105.200 10.775
202309 15.326 106.200 15.413
202312 16.791 106.800 16.791

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


DNA Chip Research  (TSE:2397) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DNA Chip Research's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=896.00/80.46
=11.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DNA Chip Research was 20.43. The lowest was 3.55. And the median was 6.87.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


DNA Chip Research Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of DNA Chip Research's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


DNA Chip Research (TSE:2397) Business Description

Traded in Other Exchanges
N/A
Address
1-1-43 Suehirocho, Tsurumi-ku, Yokohama, JPN
DNA Chip Research Inc is specializing in the development of DNA microarrays. Its major business is focused on research and development, contract research service, and diagnostic support service. The company provides a wide variety of analytical services, from DNA chips to state-of-the-art next-generation sequencing. In addition, it provides consultation on experimental planning, sample preparation, statistical analysis, and manuscript preparation, catering to researchers' needs and requirements.

DNA Chip Research (TSE:2397) Headlines

No Headlines